Facioscapulohumeral muscular dystrophy

References

• van der Maarel SM, Miller DG, Tawil R, Filippova GN, Tapscott SJ. Facioscapulohumeral muscular dystrophy: consequences of chromatin relaxation. Curr Opin Neurol 2012; 25:614 - 20; http://dx.doi.org/10.1097/WCO.0b013e328357f22d; PMID: 22892954
   PubMed Web of Science ®Google Scholar
• Lemmers RJ, Wohlgemuth M, Frants RR, Padberg GW, Morava E, van der Maarel SM. Contractions of D4Z4 on 4qB subtelomeres do not cause facioscapulohumeral muscular dystrophy. Am J Hum Genet 2004; 75:1124 - 30; http://dx.doi.org/10.1086/426035; PMID: 15467981
   PubMed Web of Science ®Google Scholar
• Lemmers RJ, van der Vliet PJ, Klooster R, Sacconi S, Camaño P, Dauwerse JG, Snider L, Straasheijm KR, van Ommen GJ, Padberg GW, et al. A unifying genetic model for facioscapulohumeral muscular dystrophy. Science 2010; 329:1650 - 3; http://dx.doi.org/10.1126/science.1189044; PMID: 20724583
   PubMed Web of Science ®Google Scholar
• Dixit M, Ansseau E, Tassin A, Winokur S, Shi R, Qian H, Sauvage S, Mattéotti C, van Acker AM, Leo O, et al. DUX4, a candidate gene of facioscapulohumeral muscular dystrophy, encodes a transcriptional activator of PITX1. Proc Natl Acad Sci U S A 2007; 104:18157 - 62; http://dx.doi.org/10.1073/pnas.0708659104; PMID: 17984056
   PubMed Web of Science ®Google Scholar
• Clapp J, Mitchell LM, Bolland DJ, Fantes J, Corcoran AE, Scotting PJ, Armour JA, Hewitt JE. Evolutionary conservation of a coding function for D4Z4, the tandem DNA repeat mutated in facioscapulohumeral muscular dystrophy. Am J Hum Genet 2007; 81:264 - 79; http://dx.doi.org/10.1086/519311; PMID: 17668377
   PubMed Web of Science ®Google Scholar
• Jones TI, Chen JC, Rahimov F, Homma S, Arashiro P, Beermann ML, King OD, Miller JB, Kunkel LM, Emerson CP Jr., et al. Facioscapulohumeral muscular dystrophy family studies of DUX4 expression: evidence for disease modifiers and a quantitative model of pathogenesis. Hum Mol Genet 2012; 21:4419 - 30; http://dx.doi.org/10.1093/hmg/dds284; PMID: 22798623
   PubMed Web of Science ®Google Scholar
• Snider L, Geng LN, Lemmers RJ, Kyba M, Ware CB, Nelson AM, Tawil R, Filippova GN, van der Maarel SM, Tapscott SJ, et al. Facioscapulohumeral dystrophy: incomplete suppression of a retrotransposed gene. PLoS Genet 2010; 6:e1001181; http://dx.doi.org/10.1371/journal.pgen.1001181; PMID: 21060811
   PubMed Web of Science ®Google Scholar
• Scionti I, Fabbri G, Fiorillo C, Ricci G, Greco F, D’Amico R, Termanini A, Vercelli L, Tomelleri G, Cao M, et al. Facioscapulohumeral muscular dystrophy: new insights from compound heterozygotes and implication for prenatal genetic counselling. J Med Genet 2012; 49:171 - 8; http://dx.doi.org/10.1136/jmedgenet-2011-100454; PMID: 22217918
   PubMed Web of Science ®Google Scholar
• Reed PW, Corse AM, Porter NC, Flanigan KM, Bloch RJ. Abnormal expression of mu-crystallin in facioscapulohumeral muscular dystrophy. Exp Neurol 2007; 205:583 - 6; http://dx.doi.org/10.1016/j.expneurol.2007.03.009; PMID: 17451686
   PubMed Web of Science ®Google Scholar
• Lemmers RJ, Tawil R, Petek LM, Balog J, Block GJ, Santen GW, Amell AM, van der Vliet PJ, Almomani R, Straasheijm KR, et al. Digenic inheritance of an SMCHD1 mutation and an FSHD-permissive D4Z4 allele causes facioscapulohumeral muscular dystrophy type 2. Nat Genet 2012; 44:1370 - 4; http://dx.doi.org/10.1038/ng.2454; PMID: 23143600
   PubMed Web of Science ®Google Scholar
• Homma S, Chen JC, Rahimov F, Beermann ML, Hanger K, Bibat GM, Wagner KR, Kunkel LM, Emerson CP Jr., Miller JB. A unique library of myogenic cells from facioscapulohumeral muscular dystrophy subjects and unaffected relatives: family, disease and cell function. Eur J Hum Genet 2012; 20:404 - 10; http://dx.doi.org/10.1038/ejhg.2011.213; PMID: 22108603
   PubMed Web of Science ®Google Scholar
• Scionti I, Greco F, Ricci G, Govi M, Arashiro P, Vercelli L, Berardinelli A, Angelini C, Antonini G, Cao M, et al. Large-scale population analysis challenges the current criteria for the molecular diagnosis of fascioscapulohumeral muscular dystrophy. Am J Hum Genet 2012; 90:628 - 35; http://dx.doi.org/10.1016/j.ajhg.2012.02.019; PMID: 22482803
   PubMed Web of Science ®Google Scholar
• Lemmers RJ, Wohlgemuth M, van der Gaag KJ, van der Vliet PJ, van Teijlingen CM, de Knijff P, Padberg GW, Frants RR, van der Maarel SM. Specific sequence variations within the 4q35 region are associated with facioscapulohumeral muscular dystrophy. Am J Hum Genet 2007; 81:884 - 94; http://dx.doi.org/10.1086/521986; PMID: 17924332
   PubMed Web of Science ®Google Scholar
• Bosnakovski D, Xu Z, Gang EJ, Galindo CL, Liu M, Simsek T, Garner HR, Agha-Mohammadi S, Tassin A, Coppée F, et al. An isogenetic myoblast expression screen identifies DUX4-mediated FSHD-associated molecular pathologies. EMBO J 2008; 27:2766 - 79; http://dx.doi.org/10.1038/emboj.2008.201; PMID: 18833193
   PubMed Web of Science ®Google Scholar
• Kowaljow V, Marcowycz A, Ansseau E, Conde CB, Sauvage S, Mattéotti C, Arias C, Corona ED, Nuñez NG, Leo O, et al. The DUX4 gene at the FSHD1A locus encodes a pro-apoptotic protein. Neuromuscul Disord 2007; 17:611 - 23; http://dx.doi.org/10.1016/j.nmd.2007.04.002; PMID: 17588759
   PubMed Web of Science ®Google Scholar
• Wallace LM, Garwick SE, Mei W, Belayew A, Coppee F, Ladner KJ, Guttridge D, Yang J, Harper SQ. DUX4, a candidate gene for facioscapulohumeral muscular dystrophy, causes p53-dependent myopathy in vivo. Ann Neurol 2011; 69:540 - 52; http://dx.doi.org/10.1002/ana.22275; PMID: 21446026
   PubMed Web of Science ®Google Scholar
• Wuebbles RD, Long SW, Hanel ML, Jones PL. Testing the effects of FSHD candidate gene expression in vertebrate muscle development. Int J Clin Exp Pathol 2010; 3:386 - 400; PMID: 20490329
   PubMed Web of Science ®Google Scholar
• Stadler G, Rahimov F, King OD, Chen JC, Robin JD, Wagner KR, Shay JW, Emerson CP Jr., Wright WE. Telomere position effect regulates DUX4 in human facioscapulohumeral muscular dystrophy. Nat Struct Mol Biol 2013; 20:671 - 8; http://dx.doi.org/10.1038/nsmb.2571; PMID: 23644600
   PubMed Web of Science ®Google Scholar
• Rahimov F, King OD, Leung DG, Bibat GM, Emerson CP Jr., Kunkel LM, Wagner KR. Transcriptional profiling in facioscapulohumeral muscular dystrophy to identify candidate biomarkers. Proc Natl Acad Sci U S A 2012; 109:16234 - 9; http://dx.doi.org/10.1073/pnas.1209508109; PMID: 22988124
   PubMed Web of Science ®Google Scholar
• Block GJ, Narayanan D, Amell AM, Petek LM, Davidson KC, Bird TD, Tawil R, Moon RT, Miller DG. Wnt/β-catenin signaling suppresses DUX4 expression and prevents apoptosis of FSHD muscle cells. Hum Mol Genet 2013; http://dx.doi.org/10.1093/hmg/ddt314; PMID: 23821646
   PubMed Web of Science ®Google Scholar
• Geng LN, Yao Z, Snider L, Fong AP, Cech JN, Young JM, van der Maarel SM, Ruzzo WL, Gentleman RC, Tawil R, et al. DUX4 activates germline genes, retroelements, and immune mediators: implications for facioscapulohumeral dystrophy. Dev Cell 2012; 22:38 - 51; http://dx.doi.org/10.1016/j.devcel.2011.11.013; PMID: 22209328
   PubMed Web of Science ®Google Scholar
• Baird DM, Britt-Compton B, Rowson J, Amso NN, Gregory L, Kipling D. Telomere instability in the male germline. Hum Mol Genet 2006; 15:45 - 51; http://dx.doi.org/10.1093/hmg/ddi424; PMID: 16311252
   PubMed Web of Science ®Google Scholar
• Gabellini D, Green MR, Tupler R. Inappropriate gene activation in FSHD: a repressor complex binds a chromosomal repeat deleted in dystrophic muscle. Cell 2002; 110:339 - 48; http://dx.doi.org/10.1016/S0092-8674(02)00826-7; PMID: 12176321
   PubMed Web of Science ®Google Scholar
• Gabellini D, D’Antona G, Moggio M, Prelle A, Zecca C, Adami R, Angeletti B, Ciscato P, Pellegrino MA, Bottinelli R, et al. Facioscapulohumeral muscular dystrophy in mice overexpressing FRG1. Nature 2006; 439:973 - 7; PMID: 16341202
   PubMed Web of Science ®Google Scholar
• Bosnakovski D, Lamb S, Simsek T, Xu Z, Belayew A, Perlingeiro R, Kyba M. DUX4c, an FSHD candidate gene, interferes with myogenic regulators and abolishes myoblast differentiation. Exp Neurol 2008; 214:87 - 96; http://dx.doi.org/10.1016/j.expneurol.2008.07.022; PMID: 18723017
   PubMed Web of Science ®Google Scholar
• Caruso N, Herberth B, Bartoli M, Puppo F, Dumonceaux J, Zimmermann A, Denadai S, Lebossé M, Roche S, Geng L, et al. Deregulation of the Protocadherin Gene FAT1 Alters Muscle Shapes: Implications for the Pathogenesis of Facioscapulohumeral Dystrophy. PLoS Genet 2013; 9:e1003550; http://dx.doi.org/10.1371/journal.pgen.1003550; PMID: 23785297
   PubMedGoogle Scholar
• Pirozhkova I, Petrov A, Dmitriev P, Laoudj D, Lipinski M, Vassetzky Y. A functional role for 4qA/B in the structural rearrangement of the 4q35 region and in the regulation of FRG1 and ANT1 in facioscapulohumeral dystrophy. PLoS One 2008; 3:e3389; http://dx.doi.org/10.1371/journal.pone.0003389; PMID: 18852887
   PubMedGoogle Scholar
• Filosto M, Tonin P, Scarpelli M, Savio C, Greco F, Mancuso M, Vattemi G, Govoni V, Rizzuto N, Tupler R, et al. Novel mitochondrial tRNA Leu(CUN) transition and D4Z4 partial deletion in a patient with a facioscapulohumeral phenotype. Neuromuscul Disord 2008; 18:204 - 9; http://dx.doi.org/10.1016/j.nmd.2007.12.005; PMID: 18343111
   PubMed Web of Science ®Google Scholar
• Korngut L, Siu VM, Venance SL, Levin S, Ray P, Lemmers RJ, Keith J, Campbell C. Phenotype of combined Duchenne and facioscapulohumeral muscular dystrophy. Neuromuscul Disord 2008; 18:579 - 82; http://dx.doi.org/10.1016/j.nmd.2008.03.011; PMID: 18586493
   PubMed Web of Science ®Google Scholar
• Lecky BR, MacKenzie JM, Read AP, Wilcox DE. X-linked and FSH dystrophies in one family. Neuromuscul Disord 1991; 1:275 - 8; http://dx.doi.org/10.1016/0960-8966(91)90101-W; PMID: 1822806
   PubMedGoogle Scholar
• Ricci G, Scionti I, Alì G, Volpi L, Zampa V, Fanin M, Angelini C, Politano L, Tupler R, Siciliano G. Rippling muscle disease and facioscapulohumeral dystrophy-like phenotype in a patient carrying a heterozygous CAV3 T78M mutation and a D4Z4 partial deletion: Further evidence for “double trouble” overlapping syndromes. Neuromuscul Disord 2012; 22:534 - 40; http://dx.doi.org/10.1016/j.nmd.2011.12.001; PMID: 22245016
   PubMed Web of Science ®Google Scholar
• Rudnik-Schöneborn S, Weis J, Kress W, Häusler M, Zerres K. Becker’s muscular dystrophy aggravating facioscapulohumeral muscular dystrophy--double trouble as an explanation for an atypical phenotype. Neuromuscul Disord 2008; 18:881 - 5; http://dx.doi.org/10.1016/j.nmd.2008.06.387; PMID: 18684626
   PubMed Web of Science ®Google Scholar
• Tonini MM, Passos-Bueno MR, Cerqueira A, Pavanello R, Vainzof M, Dubowitz V, Zatz M. Facioscapulohumeral (FSHD1) and other forms of muscular dystrophy in the same family: is there more in muscular dystrophy than meets the eye?. Neuromuscul Disord 2002; 12:554 - 7; http://dx.doi.org/10.1016/S0960-8966(02)00014-7; PMID: 12117479
   PubMed Web of Science ®Google Scholar
• Tsuji M, Kinoshita M, Imai Y, Kawamoto M, Kohara N. Facioscapulohumeral muscular dystrophy presenting with hypertrophic cardiomyopathy: a case study. Neuromuscul Disord 2009; 19:140 - 2; http://dx.doi.org/10.1016/j.nmd.2008.11.011; PMID: 19147353
   PubMed Web of Science ®Google Scholar